Finally, our results demonstrated that the antagonist of progesterone receptor, MIF, can boost programmed-death of PR-M-positive uterine leiomyoma through the Bcl-2/Beclin1 axis. The gene discussed is BCL2; the disease is Uterine leiomyoma.